Investigation of auranofin and gold-containing analogues antibacterial activity against multidrug-resistant Neisseria gonorrhoeae
Open Access
- 27 March 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 10 (1), 1-9
- https://doi.org/10.1038/s41598-020-62696-3
Abstract
Neisseria gonorrhoeae represents an urgent public health threat due to the rapid emergence of resistance to current antibiotics and the limited number of anti-gonococcal agents currently in clinical trials. This study utilized a drug repositioning strategy to investigate FDA-approved gold-containing drugs against N. gonorrhoeae. Auranofin, sodium aurothiomalate and aurothioglucose inhibited 48 clinical isolates of N. gonorrhoeae including multidrug-resistant strains at a concentration as low as 0.03 µg/mL. A time-kill assay revealed that auranofin exhibited rapid bactericidal activity against N. gonorrhoeae. Moreover, both sodium aurothiomalate and aurothioglucose did not inhibit growth of vaginal protective commensal lactobacilli. Auranofin, in combination with azithromycin, ceftriaxone, cefixime or tetracycline showed an additive effect against four N. gonorrhoeae strains, suggesting the possibility of using auranofin in dual therapy. Moreover, auranofin reduced the burden of intracellular N. gonorrhoeae by over 99% outperforming the drug of choice ceftriaxone. Auranofin was found superior to ceftriaxone in reducing the secretion of the pro-inflammatory cytokine IL-8 by endocervical cells infected with N. gonorrhoeae. Furthermore, auranofin exhibited a prolonged post-antibiotic effect over 10 h, as well as inability to generate resistant mutants. Overall, the current study suggests that repurposing gold-containing drugs, like auranofin, for treatment of gonorrhea warrants further investigation.Keywords
This publication has 45 references indexed in Scilit:
- 2012 European guideline on the diagnosis and treatment of gonorrhoea in adultsInternational Journal of STD & AIDS, 2013
- Vaginal microbiome of reproductive-age womenProceedings of the National Academy of Sciences of the United States of America, 2010
- Defining Fractional Inhibitory Concentration Index Cutoffs for Additive Interactions Based on Self-Drug Additive Combinations, Monte Carlo Simulation Analysis, and In Vitro - In Vivo Correlation Data for Antifungal Drug Combinations against Aspergillus fumigatusAntimicrobial Agents and Chemotherapy, 2010
- Antimicrobial susceptibility testing of lactic acid bacteria and bifidobacteria by broth microdilution method and EtestInternational Journal of Food Microbiology, 2009
- Frequency of Development and Associated Physiological Cost of Azithromycin Resistance in Chlamydia psittaci 6BC and C. trachomatis L2Antimicrobial Agents and Chemotherapy, 2007
- Gonorrhea: UpdateOral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 2006
- Cultivation of Neisseria gonorrhoeae in Liquid Media and Determination of Its In Vitro Susceptibilities to QuinolonesJournal of Clinical Microbiology, 2005
- The Molecular Mechanisms Used byNeisseria gonorrhoeaeTo Initiate Infection Differ between Men and WomenClinical Microbiology Reviews, 2004
- Postantibiotic Effects of Garenoxacin (BMS-284756) against 12 Gram-Positive or -Negative OrganismsAntimicrobial Agents and Chemotherapy, 2003
- Inflammatory Cytokines Produced in Response to Experimental Human GonorrheaThe Journal of Infectious Diseases, 1995